Stockscreener 앱 받기
2.02
4.12%
0.08
시간 외 거래:
1.98
-0.04
-1.98%
전일 마감가:
$1.94
열려 있는:
$2
하루 거래량:
24,255
Relative Volume:
0.54
시가총액:
$43.77M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+2.02%
1개월 성능:
-14.04%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$1.89
$2.07
1주일 범위
$1.66
$2.0881
52주 변동 폭
$1.66
$3.50
Rein Therapeutics Inc Stock (RNTX) Company Profile
명칭
Rein Therapeutics Inc
전화
(737) 802-1989
주소
12407 N. MOPAC EXPY., AUSTIN
RNTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RNTX
Rein Therapeutics Inc
|
2.02 | 43.77M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Rein Therapeutics Inc Stock (RNTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2017-07-24 | 개시 | BofA/Merrill | Buy |
| 2017-07-24 | 개시 | Jefferies | Buy |
| 2017-07-24 | 개시 | William Blair | Outperform |
Rein Therapeutics Inc 주식(RNTX)의 최신 뉴스
Daybreak West March 11: Ag chair seeks to rein in CARB costs - Agri-Pulse
OpinionThrough ‘radical transparency,’ Kennedy can finally rein in Big Pharma - AOL
Trump's Plan To Rein In Regulators Could Erode Market Trust, Says $2.3 Trillion Asset Manager - Yahoo Finance
Saratoga Springs event celebrates Belmont countdown while supporting therapeutic horses - WRGB
Carney Vows to Rein In Government Spending, Cap Public Service in Canada - Yahoo Finance
Should You Invest in Wolfspeed Inc (WOLF) Now? - The News Heater
Esco Technologies, Inc (ESE) Shares Up Despite Recent Market Volatility - The News Heater
PDD Holdings Inc ADR (PDD) Shares Rise Despite Market Challenges - The News Heater
Palantir Technologies Inc (PLTR) Stock: A Closer Look at the Analyst Ratings - The News Heater
Rein Therapeutics (RNTX) Income Statement & Balance Sheet 2025 - MarketBeat
Smart brands rein in ad spending when a rival faces a setback − here’s why - Yahoo Finance
Zimbabwe Plans New Measures to Rein In Proliferating Informal Sector - Yahoo Finance
United Therapeutics president sells shares worth $3.7 million - MSN
Rodman & Renshaw sets $8 target for Rein Therapeutics stock By Investing.com - Investing.com Canada
Analysis-Trump's digital dollar ban gives China and Europe's CBDCs free rein - Yahoo Finance
Rodman & Renshaw sets $8 target for Rein Therapeutics stock - Investing.com India
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Stock market news: Blackboxstocks +105.33%, ScanTech AI Systems +59.14% among top gainers during mid day trading - Business Upturn
Aileron Therapeutics, Inc. announced that it has received $42 million in funding from a group of investors. - Marketscreener.com
Atara stock extends losses on FDA clinical hold (ATRA:NASDAQ) - Seeking Alpha
GeneTether Therapeutics Rebrands as Rize Oncology, Focuses on Cancer Treatment - MSN
Old Lyme horse riding center gives Parkinson's patients the reins - theday.com
Free Rein Coffee Company® Expands Distribution of Free Rein Reserve™ Collection - Yahoo Canada Finance
Aileron straps in for 2025 with a new name: Rein Therapeutics - FiercePharma
Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma - Marketscreener.com
Aileron Therapeutics, Inc. Announces Board Changes - Marketscreener.com
Aileron Therapeutics, Inc. Announces Board Changes -April 01, 2019 at 06:16 am EDT - Marketscreener.com
Aileron Therapeutics to be Included in the Russell Microcap® Index - Marketscreener.com
Aileron Therapeutics Announces Appointments to Scientific Advisory Board -March 28, 2018 at 07:00 am EDT - Marketscreener.com
Aileron Therapeutics Announces the Promotion of Richard J. Wanstall to Chief Financial Officer and Treasurer - Marketscreener.com
Aileron Therapeutics Announces Board Appointments -June 24, 2019 at 08:00 am EDT - Marketscreener.com
Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference - Marketscreener.com
Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights - Marketscreener.com
Aileron Therapeutics, Inc. Announces Management Changes - Marketscreener.com
Aileron Therapeutics Announces Management Changes - Marketscreener.com
Aileron Therapeutics, Inc. Announces CEO Changes -March 12, 2024 at 08:00 am EDT - Marketscreener.com
Aileron Therapeutics Announces Management Changes -September 06, 2018 at 09:10 am EDT - Marketscreener.com
Rein Therapeutics announces name change and new ticker By Investing.com - Investing.com South Africa
Rein Therapeutics announces name change and new ticker - Investing.com
Aileron Therapeutics announces rebranding to Rein Therapeutics - MSN
Aileron Therapeutics Announces Rebranding to Rein Therapeutics - PR Newswire
Rein Therapeutics Rebrands And Focuses On Pulmonary And Fibrosis Therapies - Nasdaq
Warren Stephens steps down, turns reins of Stephens, Inc. over to his sons - KARK
New law set to rein in drug costs for many in Mass. - GazetteNET
Achilles Therapeutics sells technology assets to AstraZeneca - Seeking Alpha
Steps to rein in pharmacy benefit managers in US bill "manageable" for firms - Reuters
Tonix stock jumps on FDA review for pain drug (TNXP:NASDAQ) - Seeking Alpha
Reins of Life in South Bend rides ahead with major expansion - WSBT-TV
Empyrean Technology gives control to CEC after U.S. blacklisting — China’s top developer of chip design systems hands reins to state-owned firm - Yahoo Finance
Saudi Arabia to rein in spending next year - Yahoo! Voices
Rein Therapeutics Inc (RNTX) 재무 분석
Rein Therapeutics Inc (RNTX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.39%
0.55%
자본화:
|
볼륨(24시간):